Focusing on the provision of treatment--not the etiology or diagnosis--this book reviews the thinking of many professionals on a broad range of dual diagnosis issues. Topics include: the biology of addictive and psychiatric disorders; dual diagnosis in adolescents, minority populations, and women; relapse prevention strategies; and more.
|Product dimensions:||5.30(w) x 8.30(h) x 0.70(d)|
About the Author
Norman S. Miller, M.D., is Professor of Psychiatry and Medicine, College of Human Medicine, Director of Addiction Medicine, Michigan State University, and Medical Consultant, Division of Substance Abuse Services, State of Michigan. His clinical and research interests are treatment outcome, prescription medications, and medical education. He is a member of Alpha Omega Alpha, Howard University Medical College. He is certified in Addiction Medicine. Dr. Miller has a Diplomat, American Board of Psychiatry and Neurology separately in Psychiatry, Neurology, Addiction Psychiatry, and Forensic Psychiatry. He completed a residency in psychiatry at Johns Hopkins Hospital and a residency in neurology and a fellowship in clinical pharmacology at the University of Minnesota. He appears in Who's Who in America (and International). He is past President of the Illinois Society of Addiction Medicine. For the American Society for Addiction Medicine (ASAM), he is Regional Director of the Midwest Region and Editor of Principles of Addiction Medicine (First Edition), Program and Publication Committees. He has coordinated symposia, courses and workshops for the ASAM annual meeting. He speaks before national and international audiences, and presents at state and federal conferences and universities and medical schools. Dr. Miller has published 250 medical/scientific articles, book chapters, and reviews, and 12 books on addiction medicine. He is a fellow in the American Psychopathological Association, and a member of the American Psychiatric Association, the American Society for Addiction Medicine, and the American National Professional Committees. He is a member of the Task Force on Treatment for the Office of National Drug Control Policy (ONDCP), Office of the President of the United States; a member of the Center for Substance Abuse Treatment (CSAT) on Screening, Assessment, and Treatment Planning for patients with Coexisting Mental Illness and Alcohol and Other Drug (AOD) Abuse; and co-chair of the Task Force for Undergraduate Medical Education, Association for Medical Education and Research in Substance Abuse (AMERSA).